Banque Pictet & Cie SA trimmed its position in shares of CRH plc (NYSE:CRH - Free Report) by 20.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 87,117 shares of the construction company's stock after selling 22,488 shares during the quarter. Banque Pictet & Cie SA's holdings in CRH were worth $8,060,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Deseret Mutual Benefit Administrators acquired a new position in CRH during the 3rd quarter valued at about $25,000. Heck Capital Advisors LLC purchased a new position in shares of CRH during the fourth quarter valued at approximately $32,000. Meeder Asset Management Inc. bought a new stake in CRH during the third quarter worth $35,000. Baillie Gifford & Co. grew its holdings in CRH by 70.7% during the third quarter. Baillie Gifford & Co. now owns 391 shares of the construction company's stock worth $36,000 after buying an additional 162 shares in the last quarter. Finally, Spire Wealth Management purchased a new stake in CRH in the 4th quarter valued at $57,000. 62.50% of the stock is currently owned by institutional investors.
CRH Stock Up 2.0 %
CRH stock traded up $2.14 during midday trading on Tuesday, reaching $110.44. The stock had a trading volume of 7,741,791 shares, compared to its average volume of 3,966,135. The firm has a market capitalization of $75.01 billion, a PE ratio of 22.09, a P/E/G ratio of 1.18 and a beta of 1.30. CRH plc has a 12 month low of $71.18 and a 12 month high of $110.97. The firm's 50-day moving average price is $97.47 and its 200 day moving average price is $94.00.
Analysts Set New Price Targets
Several research firms have recently issued reports on CRH. HSBC initiated coverage on shares of CRH in a research note on Monday, November 11th. They issued a "buy" rating and a $116.00 target price for the company. JPMorgan Chase & Co. increased their price objective on shares of CRH from $114.00 to $116.00 and gave the company an "overweight" rating in a research note on Wednesday, November 20th. Barclays started coverage on CRH in a research note on Tuesday, October 29th. They issued an "overweight" rating and a $110.00 target price on the stock. DA Davidson increased their price target on CRH from $110.00 to $120.00 and gave the company a "buy" rating in a research report on Monday, November 11th. Finally, Hsbc Global Res upgraded CRH to a "strong-buy" rating in a research note on Monday, November 11th. One investment analyst has rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $107.75.
View Our Latest Research Report on CRH
About CRH
(
Free Report)
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services.
See Also

Before you consider CRH, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CRH wasn't on the list.
While CRH currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.